Correlation Between Nokia and Dermapharm Holding

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nokia and Dermapharm Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nokia and Dermapharm Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nokia and Dermapharm Holding SE, you can compare the effects of market volatilities on Nokia and Dermapharm Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nokia with a short position of Dermapharm Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nokia and Dermapharm Holding.

Diversification Opportunities for Nokia and Dermapharm Holding

-0.32
  Correlation Coefficient

Very good diversification

The 3 months correlation between Nokia and Dermapharm is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Nokia and Dermapharm Holding SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dermapharm Holding and Nokia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nokia are associated (or correlated) with Dermapharm Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dermapharm Holding has no effect on the direction of Nokia i.e., Nokia and Dermapharm Holding go up and down completely randomly.

Pair Corralation between Nokia and Dermapharm Holding

Assuming the 90 days trading horizon Nokia is expected to generate 1.42 times more return on investment than Dermapharm Holding. However, Nokia is 1.42 times more volatile than Dermapharm Holding SE. It trades about 0.09 of its potential returns per unit of risk. Dermapharm Holding SE is currently generating about 0.03 per unit of risk. If you would invest  334.00  in Nokia on September 27, 2024 and sell it today you would earn a total of  90.00  from holding Nokia or generate 26.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Nokia  vs.  Dermapharm Holding SE

 Performance 
       Timeline  
Nokia 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Nokia are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Nokia may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Dermapharm Holding 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Dermapharm Holding SE are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Dermapharm Holding may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Nokia and Dermapharm Holding Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nokia and Dermapharm Holding

The main advantage of trading using opposite Nokia and Dermapharm Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nokia position performs unexpectedly, Dermapharm Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermapharm Holding will offset losses from the drop in Dermapharm Holding's long position.
The idea behind Nokia and Dermapharm Holding SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Share Portfolio
Track or share privately all of your investments from the convenience of any device